-- MDNA11 and anti-PD-1 combination leads to complete responses in a murine solid tumor model -- Preclinical data demonstrates the...
LA JOLLA, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- MatriSys Bioscience, a company harnessing beneficial bacteria to treat inflammatory skin...
COSELA Added to Both the NCCN Treatment Guidelines for Small Cell Lung Cancer and the NCCN Supportive Care Guidelines for...
SOUTH SAN FRANCISCO, Calif., March 25, 2021 (GLOBE NEWSWIRE) -- Today Annexon, Inc. (“Annexon”) (Nasdaq: ANNX), a clinical-stage biopharmaceutical company...
Submitted a Special Protocol Assessment to the FDA for Phase III program evaluating vilobelimab in Hidradenitis Suppurativa (HS) in Q1...
Philips Airfryer XXL Philips SpeedPro Max March 25, 2021 Transaction values Domestic Appliances at an enterprise value of approximately EUR...
– Received Orphan Drug Designation by the U.S. Food and Drug Administration for INZ-701 for treatment of ABCC6 deficiency –...
SEATTLE, March 25, 2021 (GLOBE NEWSWIRE) -- Accolade, Inc. (Nasdaq: ACCD) (“Accolade”) announced the pricing of $250 million aggregate principal...
CONVENING OF THE ORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF 30 APRIL 2021 The shareholders are invited to attend the ordinary general...
Toronto, Ontario--(Newsfile Corp. - March 25, 2021) - Therma Bright Inc. (TSXV: THRM) ("Therma" or the "Company"), developer of the...
Eight custom measures receive approval, raising the bar on oncology patient care IRVING, Texas--(BUSINESS WIRE)--For the fifth consecutive year, McKesson...
LONDON--(BUSINESS WIRE)--$LIVN--LivaNova PLC (NASDAQ:LIVN), a market-leading medical technology and innovation company, will host a conference call to discuss its first...
Equal Opportunity magazine readers recognize Philips for its commitment to fostering a diverse and inclusive workforce CAMBRIDGE, Mass.--(BUSINESS WIRE)--Royal Philips...
SAN MATEO, Calif.--(BUSINESS WIRE)--#NLP--For Health Fidelity Inc., a company that provides innovative technologies for the value-based care era, 2021 marks...
Subjects treated with cytisinicline were 55% more likely to quit smoking at 6 months and experienced significantly fewer side effects...
World-Class continues to show substantial revenue growth quarter-over-quarter with revenue of $2,649,140 for the quarter ended January 31, 2021 compared...
Non-binding Heads of Terms for Co-development of MTX110; Unaudited Headline Results for the Year Ended 31 December 2020 ABINGDON, UK / ACCESSWIRE...
VERY STRONG FINANCIAL RESULTS: 12% INCREASE IN GROUP REVENUES BEATING GUIDANCE DESPITE PANDEMIC UNIQUE INNOVATION PLATFORMS AND INFRASTRUCTURE SUPPORT LONG-TERM...